Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly peopleGuidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease researchRedox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stressPharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathiesFrequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyEvaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosisBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseMutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSA harmonized classification system for FTLD-TDP pathologyExome sequencing reveals VCP mutations as a cause of familial ALSImaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesT1rho MRI of Alzheimer's diseaseBrain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosisImpact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014At the interface of sensory and motor dysfunctions and Alzheimer's disease.Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy modelsCognitive profile of LRRK2-related Parkinson's diseaseLower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeRarity of the Alzheimer disease-protective APP A673T variant in the United StatesPARK10 is a major locus for sporadic neuropathologically confirmed Parkinson diseaseUbiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisClinicopathological correlations in corticobasal degenerationAssociation of ABCA2 expression with determinants of Alzheimer's diseaseEnhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse modelDistinct α-synuclein strains differentially promote tau inclusions in neuronsTDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron diseaseAxonal transport defects: a common theme in neurodegenerative diseasesAltered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2An Alzheimer's Disease-Derived Biomarker Signature Identifies Parkinson's Disease Patients with DementiaBuilding a roadmap for developing combination therapies for Alzheimer's diseaseAdvancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational SummitPolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeatsThe Alzheimer's disease neuroimaging initiative: progress report and future plansCommon variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationCommon variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study
P50
Q22253051-B96DD9EE-2ECB-4455-8D9A-01603938084BQ24289435-E48A483A-44FA-482B-8A05-44F98AA4EDA7Q24300438-18382ECA-3789-441E-9EA3-A08A51251714Q24338241-26D750CF-9C43-438F-958E-7F7B37FA847AQ24339508-9453BADB-4306-442E-BD47-A084AD87F359Q24554351-C7C67148-4252-4A34-8FA3-9E1DFEC4D1B6Q24600803-370A5EF0-1868-4424-B5A7-83985E386F0FQ24605104-CABC9D71-68B7-4DE8-96DC-7122F3D9B84DQ24622136-6B3164BA-9E2E-4AD3-9DC3-6B525CF47A47Q24629495-E1BE9593-667C-4FF1-8A1C-50B1DF3F3065Q24630756-C48689C1-C199-449E-B536-E9032F639C29Q24631513-287CC514-9B85-45B9-B547-1A32EB6A25EAQ24642726-75F57368-9136-4498-89B8-B6D4682C57A1Q24657595-42E612CA-86F9-46BA-9BD2-6B5C67CC94DEQ24793976-1AE42F84-51EB-4B26-9BBB-DC3FF4018C44Q26801629-A568B06E-9094-45EC-AC4C-F4B7EF9B6679Q27000410-B1031ACE-6639-46E0-9532-B100D1B92355Q27308146-567C574C-B516-40C4-932D-B37E6A0725B3Q27333093-3AA2D93C-DA1E-4735-AAF7-9D2D558D7A1BQ27333275-1AF65540-7A30-4D4C-893C-BF70FCF7D12EQ27346292-6A128CA1-FE95-472A-8AD3-A7F1D7BD8AEAQ27349225-BB14C452-E3AB-40E1-97A7-1A6309214265Q28131672-A96826B2-BE14-4B15-9F7C-053D4953A2E4Q28245070-ACAFE1D5-8A47-4B15-A8E2-DEB3E2037C19Q28262744-CBE23233-7DC8-4651-990E-A56791745014Q28278161-30675C28-0BAB-4D56-B40B-6E5399F25D78Q28293967-42EA6B55-6724-4908-A525-CAA4D52F42D8Q28301503-73FBC50E-683D-45A1-85C7-1C660E729BDDQ28302119-E40DFF38-E7DF-4476-96F7-EC9222277088Q28303208-59BB3B12-283E-4931-89C0-6248198002FDQ28552902-5315AF79-27BB-49EC-ABC4-A55F05A9B9E6Q28611100-55366E33-0D93-4FA3-B977-8CB9285BEE75Q28709591-6C91D36D-0708-4D09-8438-46A849116246Q28741564-A6E16A2D-F76B-434C-B20C-29A68DAD9C23Q28749585-C5F7FC74-F490-4517-BA27-E3E7B107F9ABQ28943325-00B99FBE-C3DA-4335-BFF1-73FCBC1136B0Q29417137-609B73AD-8CF5-4DEC-8326-A3D850ACAD4BQ30373366-223BD99E-173C-4B91-8ED4-23334FBBFAF8Q30434949-90B8C7F7-FB1F-4688-A607-D2BAD1767D77Q30459046-A68D63E5-5CDD-48C8-AC60-1A512A95CFAA
P50
description
American medical researcher
@en
US-amerikanischer medizinischer Wissenschaftler
@de
investigador médicu estauxunidense
@ast
name
John Q. Trojanowski
@ast
John Q. Trojanowski
@ca
John Q. Trojanowski
@de
John Q. Trojanowski
@en
John Q. Trojanowski
@es
John Q. Trojanowski
@fr
John Q. Trojanowski
@nl
John Q. Trojanowski
@sl
約翰·Q·特羅揚沃斯基
@zh
type
label
John Q. Trojanowski
@ast
John Q. Trojanowski
@ca
John Q. Trojanowski
@de
John Q. Trojanowski
@en
John Q. Trojanowski
@es
John Q. Trojanowski
@fr
John Q. Trojanowski
@nl
John Q. Trojanowski
@sl
約翰·Q·特羅揚沃斯基
@zh
prefLabel
John Q. Trojanowski
@ast
John Q. Trojanowski
@ca
John Q. Trojanowski
@de
John Q. Trojanowski
@en
John Q. Trojanowski
@es
John Q. Trojanowski
@fr
John Q. Trojanowski
@nl
John Q. Trojanowski
@sl
約翰·Q·特羅揚沃斯基
@zh
P166
P69
P1015
P214
P244
P268
P269
P1015
P1207
n2004038067
P166
P1960
pW40gIAAAAAJ
P21
P213
0000 0001 1767 304X
P214
P2381
P244
P268
P269
P31
P569
1946-01-01T00:00:00Z